Hydroquinone, a Reactive Metabolite of Benzene, Inhibits NF-κB in Primary Human CD4+T Lymphocytes
- 30 April 1998
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 149 (2) , 178-184
- https://doi.org/10.1006/taap.1998.8369
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Cigarette Tar Componentp-Benzoquinone Blocks T-Lymphocyte Activation by Inhibiting Interleukin-2 Production, but Not CD25, ICAM-1, or LFA-1 ExpressionToxicology and Applied Pharmacology, 1997
- Inhibition of Human T Lymphoblast Proliferation by HydroquinoneToxicology and Applied Pharmacology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Phospholipases and protein kinases during phagocyte activationCurrent Opinion in Immunology, 1994
- NF-κB Subunit Regulation in Nontransformed CD4 + T LymphocytesScience, 1992
- Exposures to Benzene and Other Volatile Compounds from Active and Passive SmokingArchives of environmental health, 1987
- Inhibition of RNA synthesis and interleukin-2 production in lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzoquinoneToxicology Letters, 1985
- Inhibition of mRNA synthesis in rabbit bone marrow nuclei in vitro by quinone metabolites of benzeneChemico-Biological Interactions, 1984
- Tumor promoters and cocarcinogens in tobacco carcinogenesis.Environmental Health Perspectives, 1983
- SMOKING AND IMMUNITYThe Lancet, 1973